Modulation of CYP2E1 metabolic activity in a cohort of confirmed caffeine ingesting pregnant women with preterm offspring

被引:0
作者
M. R. Alcorta-García
C. N. López-Villaseñor
G. Sánchez-Ferrer
H. Flores-Mendoza
F. Castorena-Torres
M. A. Aguilar-Torres
C. M. Sepúlveda-Treviño
J. A. Hernández-Hernández
R. C. López-Sánchez
V. J. Lara-Díaz
机构
[1] Tecnologico de Monterrey, Escuela de Medicina y Ciencias de la Salud, Avenida Ignacio Morones Prieto 3000 poniente, Colonia Doctores, Monterrey, CP 64710, Nuevo León
[2] Hospital Regional Materno Infantil, Secretaria de Salud, Gobierno del Estado de Nuevo León, Avenida San Rafael 450, Colonia San Rafael, Ciudad Guadalupe, CP 67140, Nuevo León
关键词
Caffeine; Cytochrome P-450 CYP1A2 inducers; Cytochrome P-450 CYP1A2 inhibitors; Cytochrome P-450 CYP2E1 inducers; Cytochrome P-450 CYP2E1 inhibitors; Cytochrome P-450 Enzyme System; Infant; Premature; Premature birth;
D O I
10.1186/s40348-020-00096-3
中图分类号
学科分类号
摘要
Background: To ascertain interactions of caffeine ingestion, food, medications, and environmental exposures during preterm human gestation, under informed consent, we studied a cohort of Mexican women with further preterm offspring born at ≤ 34 completed weeks. At birth, blood samples were taken from mothers and umbilical cords to determine caffeine and metabolites concentrations and CYP1A2 (rs762551) and CYP2E1 (rs2031920, rs3813867) polymorphisms involved in caffeine metabolism. Results: In 90 pregnant women who gave birth to 98 preterm neonates, self-informed caffeine ingestion rate was 97%, laboratory confirmed rate was 93 %. Theobromine was the predominant metabolite found. Consumption of acetaminophen correlated significantly with changes in caffeine metabolism (acetaminophen R2 = 0.637, p = 0.01) due to activation of CYP2E1 alternate pathways. The main caffeine source was cola soft drinks. Conclusion: Environmental exposures, especially acetaminophen ingestion during human preterm pregnancy, can modulate CYP2E1 metabolic activity. © 2020, The Author(s).
引用
收藏
相关论文
共 43 条
[1]  
Fredholm B.B., Battig K., Holmen J., Et al., Actions of caffeine in the brain with special reference to factors that contribute to its widespread use, Pharmacol Rev, 51, pp. 83-133, (1999)
[2]  
Aden U., Methylxanthines During Pregnancy and Early Postnatal Life, Methylxanthines, pp. 373-389, (2010)
[3]  
Moura-Nunes N., Farah A., Caffeine Consumption and Health, (2012)
[4]  
Grosso L.M., Bracken M.B., Caffeine metabolism, genetics, and perinatal outcomes: A review of exposure assessment considerations during pregnancy, Ann Epidemiol, 15, pp. 460-466, (2005)
[5]  
Tsutsumi K., Kotegawa T., Matsuki S., Et al., The effect of pregnancy on cytochrome P4501A2, xanthine oxidase, and N-acetyltransferase activities in humans, Clin Pharmacol Ther, 70, pp. 121-125, (2001)
[6]  
Tracy T.S., Venkataramanan R., Glover D.D., Et al., Temporal changes in drug metabolism (CYP1A2, CYP2D6 and CYP3A Activity) during pregnancy, Am J Obstet Gynecol, 192, pp. 633-639, (2005)
[7]  
Yu T., Campbell S.C., Stockmann C., Et al., Pregnancy-induced changes in the pharmacokinetics of caffeine and its metabolites, J Clin Pharmacol, 56, pp. 590-596, (2016)
[8]  
Tasnif Y., Morado J., Hebert M.F., Pregnancy-related pharmacokinetic changes, Clin Pharmacol Ther, 100, pp. 53-62, (2016)
[9]  
Hakkola J., Pasanen M., Hukkanen J., Pelkonen O., Maenpaa J., Edwards R.J., Boobis A.R., Raunio H., Expression of xenobiotic-metabolizing cytochrome P450 Forms in human full-term placenta, Biochemical Pharmacology, 51, 4, pp. 403-411, (1996)
[10]  
Bracken M.B., Triche E., Grosso L., Et al., Heterogeneity in assessing self-reports of caffeine exposure: Implications for studies of health effects, Epidemiology, 13, pp. 165-171, (2002)